Open-Angle Glaucoma (OAG) Global Market Report 2025
상품코드:1717263
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
개방각 녹내장(OAG) 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.5%의 연평균 복합 성장률(CAGR)로 84억 2,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중의 성장은 병용요법에 대한 수요 증가, 맞춤형 의료에 대한 관심 증가, 녹내장 치료에 대한 상환 정책 개선, 생활습관으로 인한 안질환 증가, 비침습적 진단법에 대한 선호도 증가 등의 요인에 기인할 것으로 예측됩니다. 예측 기간을 형성할 것으로 예상되는 주요 동향으로는 녹내장 진단을 위한 AI 도입 확대, 녹내장 외래 수술로의 전환, 서방형 녹내장 임플란트 사용 증가, 안압 모니터링을 위한 웨어러블 기술 통합 확대, 의료기기 제조의 지속가능성에 대한 관심 증가 등이 있습니다.
안질환에 대한 인식이 높아짐에 따라 향후 개방각 녹내장(OAG) 시장의 성장을 촉진할 것으로 예측됩니다. 안질환은 눈의 구조, 기능, 시력에 영향을 미치는 상태를 말하며, 안구건조증과 같은 경미한 문제부터 녹내장, 황반변성과 같은 심각한 질환까지 다양합니다. 이러한 질병의 유병률 증가는 인구 고령화, 스크린 사용 시간 증가, 당뇨병 유병률 증가, 환경 오염, 눈 건강에 악영향을 미치는 생활습관 선택 등의 요인에 의해 영향을 받습니다. 개방각 녹내장(OAG)은 특히 노인 실명의 주요 원인으로, 돌이킬 수 없는 시력 저하를 예방하기 위해 정기적인 안과 검진, 조기 발견 및 적시 치료의 중요성을 강조하고 있습니다. 예를 들어 2023년 10월 영국에 본부를 둔 시력 상실 자선단체인 영국 왕립시각장애인협회(RNIB)는 2021/22년 영국에서 안과 외래 진료 예약이 800만 건을 돌파하여 가장 많이 찾는 진료과가 되었다고 보고했습니다. 또한 현재 200만 명이 넘는 시력 상실자는 2050년까지 두 배로 증가하여 400만 명을 넘어설 것으로 예측됩니다. 이에 따라 안질환에 대한 인식이 높아지면서 개방각 녹내장(OAG) 시장의 성장을 촉진하고 있습니다.
개방각녹내장(OAG) 시장의 주요 기업은 저침습 녹내장 장비(MIGD)와 같은 혁신적인 솔루션 개발에 주력하고 있으며, 기존 치료법에 대한 의존도를 줄이면서 원발성 개방각 녹내장을 관리할 수 있는 첨단 저침습적 대안을 제공합니다. 최소침습 녹내장 장비(MIGD)에는 작은 절개와 안구 조직 손상을 최소화하여 녹내장 환자의 안압을 낮추는 것을 목표로 하는 다양한 수술용 임플란트 및 기술이 포함됩니다. 예를 들어 2023년 12월 벨기에에 본사를 둔 의료 기술 기업 iSTAR Medical은 네덜란드에서 MINIject를 발표했습니다. 이 원발성 개방각 녹내장의 생물학적 통합 치료는 독자적인 다공성 STAR 소재를 사용하여 체액 유출을 개선하고 안압을 낮추며, MINIject는 기존 치료법의 필요성을 줄임으로써 녹내장 치료에 큰 진전을 가져와 돌이킬 수 없는 실명의 주요 원인인 녹내장에 더 안전하고 효과적인 치료법을 제공합니다. 효과적인 치료법을 제공합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 개방각 녹내장(OAG) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 개방각 녹내장(OAG) 시장 : 성장률 분석
세계의 개방각 녹내장(OAG) 시장 실적 : 규모와 성장, 2019-2024
세계의 개방각 녹내장(OAG) 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 개방각 녹내장(OAG) TAM(Total Addressable Market)
제6장 시장 세분화
세계의 개방각 녹내장(OAG) 시장 : 질환 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
개방각 녹내장
폐쇄각 녹내장
기타 질병 유형
세계의 개방각 녹내장(OAG) 시장 : 약제 클래스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
프로스타글란딘 유사체
베타 차단약
아드레날린 작용제
탄산탈수소효소 저해제
기타 약물 클래스
세계의 개방각 녹내장(OAG) 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
홈케어
전문 클리닉
기타 최종사용자
세계의 개방각 녹내장(OAG) 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
온라인 약국
소매 약국
세계의 개방각 녹내장(OAG) 시장, 개방각 녹내장의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 개방각 녹내장(OAG) 시장, 기타 질환 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
정상 안압 녹내장
선천성 녹내장
연발성 녹내장
제7장 지역별·국가별 분석
세계의 개방각 녹내장(OAG) 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 개방각 녹내장(OAG) 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
개방각 녹내장(OAG) 시장 : 경쟁 구도
개방각 녹내장(OAG) 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Teva Pharmaceutical Industries Ltd.
Boston Scientific
Alcon Inc.
Bausch Health Companies Inc.
Hoya Corporation
Sun Pharmaceutical Industries Ltd.
Santen Pharmaceuticals
Mallinckrodt Pharmaceuticals
Thea Pharma
Glaukos Corporation
Quantel Medical
EyePoint Pharmaceuticals Inc.
iSTAR Medical
Nicox Ophthalmics
Visus Therapeutics
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
개방각 녹내장(OAG) 시장 2029 : 새로운 기회를 제공하는 국가
개방각 녹내장(OAG) 시장 2029 : 새로운 기회를 제공하는 부문
개방각 녹내장(OAG) 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁의 전략
제36장 부록
KSA
영문 목차
영문목차
Open-angle glaucoma (OAG) is a chronic and progressive eye condition in which the drainage canals in the eye gradually become blocked, causing an increase in intraocular pressure that damages the optic nerve. This damage typically occurs without noticeable symptoms until significant vision loss has occurred. Treatment focuses on lowering intraocular pressure to prevent further optic nerve damage and preserve vision through medications, laser therapies, or surgical procedures.
The main types of open-angle glaucoma (OAG) include open-angle glaucoma, angle-closure glaucoma, and other variants. Open-angle glaucoma is characterized by increased intraocular pressure, which leads to slow optic nerve damage and potential vision loss, often without early warning signs. The medications used to treat this condition include prostaglandin analogs, beta blockers, adrenergic agonists, carbonic anhydrase inhibitors, and others. The primary end users of these treatments include hospitals, homecare settings, specialty clinics, and more. These treatments are distributed through various channels such as hospital pharmacies, online pharmacies, and retail pharmacies.
The open-angle glaucoma (OAG) market research report is one of a series of new reports from The Business Research Company that provides open-angle glaucoma (OAG) market statistics, including open-angle glaucoma (OAG) industry global market size, regional shares, competitors with open-angle glaucoma (OAG) market share, detailed open-angle glaucoma (OAG) market segments, market trends and opportunities, and any further data you may need to thrive in the open-angle glaucoma (OAG) industry. This open-angle glaucoma (OAG) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The open-angle glaucoma (OAG) market size has grown strongly in recent years. It will grow from $6.13 billion in 2024 to $6.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth during the historic period can be attributed to factors such as the rising prevalence of glaucoma in aging populations, increasing awareness about the early detection of eye diseases, higher healthcare expenditure, government initiatives supporting vision care programs, and the global expansion of ophthalmology practices.
The open-angle glaucoma (OAG) market size is expected to see strong growth in the next few years. It will grow to $8.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth during the forecast period can be attributed to factors such as the increasing demand for combination therapies, a growing emphasis on personalized medicine, improved reimbursement policies for glaucoma treatments, a rise in lifestyle-induced ocular conditions, and a growing preference for non-invasive diagnostic methods. Key trends expected to shape the forecast period include the growing adoption of AI in glaucoma diagnostics, a shift toward outpatient surgical procedures for glaucoma, an increased use of sustained-release glaucoma implants, greater integration of wearable technology for monitoring intraocular pressure, and a heightened focus on sustainability in the manufacturing of medical devices.
The increasing awareness of eye diseases is expected to drive the growth of the open-angle glaucoma (OAG) market in the future. Eye illnesses refer to conditions that affect the eyes' structure, function, or vision, ranging from minor issues such as dry eye to more severe conditions such as glaucoma and macular degeneration. The rising prevalence of these conditions is influenced by factors such as aging populations, extended screen time, higher rates of diabetes, environmental pollution, and lifestyle choices that negatively affect eye health. Open-angle glaucoma (OAG), which is a leading cause of blindness, particularly in older adults, highlights the importance of regular eye exams, early detection, and timely treatment to prevent irreversible vision loss. For example, in October 2023, the Royal National Institute of Blind People (RNIB), a UK-based charity for sight loss, reported that eye care outpatient appointments in the UK surpassed eight million in 2021/22, making it the most requested medical specialty. Furthermore, the number of people experiencing sight loss, which currently exceeds two million, is expected to double to over four million by 2050. As a result, the rising awareness of eye illnesses is fueling the growth of the open-angle glaucoma (OAG) market.
Leading companies in the open-angle glaucoma (OAG) market are focusing on the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to offer advanced, less invasive options for managing primary open-angle glaucoma while reducing dependence on traditional treatments. A minimally invasive glaucoma device (MIGD) includes various surgical implants and techniques aimed at lowering intraocular pressure in glaucoma patients through small incisions and minimal disturbance to ocular tissues. For example, in December 2023, iSTAR Medical, a medtech company based in Belgium, introduced MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma uses a unique porous STAR material to improve fluid outflow and lower intraocular pressure. By reducing the need for traditional therapies, MINIject marks a significant advancement in glaucoma treatment, providing a safer and more effective management option for this major cause of irreversible blindness.
In July 2024, Alcon Inc., an ophthalmology company based in Switzerland, acquired BELKIN Vision Ltd. for $81 million. This acquisition is intended to strengthen Alcon's glaucoma portfolio by incorporating the direct selective laser trabeculoplasty (DSLT) device, an advanced first-line laser treatment for managing open-angle glaucoma. The acquisition supports Alcon's strategy to expand global access to innovative and minimally invasive glaucoma treatments. BELKIN Vision Ltd., based in Israel, is a medical device company that specializes in providing devices for the treatment of open-angle glaucoma.
Major players in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Thea Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, and Inotek Pharmaceuticals.
North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in open-angle glaucoma (OAG) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the open-angle glaucoma (OAG) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The open-angle glaucoma (OAG) market consists of revenues earned by entities by providing services such as optometric services, surgical interventions, medication management, and patient education and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The open-angle glaucoma (OAG) market also includes sales of tonometers, visual field analyzers, and lubricating eye drops. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Open-Angle Glaucoma (OAG) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on open-angle glaucoma (oag) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for open-angle glaucoma (oag) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The open-angle glaucoma (oag) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Disease Type: Open Angle Glaucoma; Angle Closure Glaucoma; Other Disease Type
2) By Drug Class: Prostaglandin Analog; Beta Blockers; Adrenergic Agonist; Carbonic Anhydrase Inhibitors; Others Drug Class
3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG); Secondary Open-Angle Glaucoma
3. Open-Angle Glaucoma (OAG) Market Trends And Strategies
4. Open-Angle Glaucoma (OAG) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Open-Angle Glaucoma (OAG) Growth Analysis And Strategic Analysis Framework
5.1. Global Open-Angle Glaucoma (OAG) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Open-Angle Glaucoma (OAG) Market Growth Rate Analysis
5.4. Global Open-Angle Glaucoma (OAG) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Open-Angle Glaucoma (OAG) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Open-Angle Glaucoma (OAG) Total Addressable Market (TAM)
6. Open-Angle Glaucoma (OAG) Market Segmentation
6.1. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Open Angle Glaucoma
Angle Closure Glaucoma
Other Disease Type
6.2. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prostaglandin Analog
Beta Blockers
Adrenergic Agonist
Carbonic Anhydrase Inhibitors
Others Drug Class
6.3. Global Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users
6.4. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.5. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Open Angle Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Primary Open-Angle Glaucoma (POAG)
Secondary Open-Angle Glaucoma
6.6. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Angle-Closure Glaucoma
Chronic Angle-Closure Glaucoma
6.7. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Other Disease Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Normal-Tension Glaucoma
Congenital Glaucoma
Secondary Glaucoma
7. Open-Angle Glaucoma (OAG) Market Regional And Country Analysis
7.1. Global Open-Angle Glaucoma (OAG) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Open-Angle Glaucoma (OAG) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
